EuroBiotech: More Articles of Note

> Freeline presented early clinical data on its Fabry disease gene therapy. Participants experienced a three- to four-fold increase in plasma αGLA levels. Statement  

> Alderley Park opened a 150,000-square-foot building to house tech startups. The site will enable startups working on drug discovery technologies to base themselves near to biopharma companies. Release  

> AurorA-TT, Rottapharm Biotech and Italfarmaco teamed up to create a biotech investment firm. The company, AurorA Science, will make investments of up to €5 million ($5.5 million) to support preclinical and early clinical development. Statement

> Inotrem added €5 million to its series B round. The money, coupled to a new €13 million credit line, will support a phase 2b trial in septic shock patients. Release 

> A phase 2 trial of Oculis’ diabetic macular edema drug met its efficacy endpoints. Statement